
Adrienne Rivlin, Partner, L.E.K. Consulting
Advertisement

Dr. Adrienne Rivlin is a partner in L.E.K.’s Healthcare practice, based in the London office. She advises private and public sector organisations across the pharmaceutical, biotech, medical device and consumer healthcare sectors on their critical commercial challenges, including corporate and portfolio strategy development; product launch; pricing and market access; clinical governance structures and processes; and commercial and regulatory due diligence.
Email: a.rivlin@lek.com
Articles by Adrienne Rivlin, Partner, L.E.K. Consulting

Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk’s Stock Reacts to Unsuccessful Phase III Trial Results
2
What Does the List of Approved Drugs Reveal About FDA's Priority Review Voucher Program?
3
Winning the Next Era of Direct-to-Patient Drug Distribution: Why End-to-End Integration Matters More Than Assembly
4
Eye Care and Earned Media: What Makes Pharma Stories Newsworthy
5
